Biotechnology Company Announces Successful Preclinical Study Results For Psoriasis Treatment
Promising In-Vivo Results for Scinai Immunotherapeutics' Psoriatic Human Skin Model.
Disclaimer: This article is intended for informational purposes only and does not constitute medical advice or endorsement of any product. Consult with a healthcare professional for medical advice and treatment options.
Real-time information is available daily at https://stockregion.net